Estudio de la inclusión de la terapia con el inhibidor de janus quinasa, citrato de tofacitinib (xeljanz®) para el tratamiento de los pacientes con artritis reumatoide en Costa Rica. TFG Farmacia

By: Contributor(s): Material type: TextTextPublication details: San José, Costa Rica UIA 2020, ii cuatrimestreDescription: 143 pSubject(s): DDC classification:
  • TCD 10471
Dissertation note: TCD 10471 / Licenciatura de Farmacia
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Date due Barcode
TFG en CD TFG en CD Biblioteca Sede Central San José TCD 10471 (Browse shelf(Opens below)) Available 49374

TCD 10471 / Licenciatura de Farmacia

There are no comments on this title.

to post a comment.